Porous hydrogel microspheres and preparation method and application thereof

By mixing hydrogels on the droplet microfluidic chip into gel phases and porous phases, and removing porous phases through ultraviolet light to form porous hydrogel microspheres, the limited cell regeneration ability of bone and joint cartilage diseases is solved. Problem, achieving support for cell proliferation and stretching, provides effective therapeutic materials for cartilage defects.

CN118420932BActive Publication Date: 2024-11-01SICHUAN CELL TISSUE BANK ENGINEERING TECHNOLOGY CO LTD
View PDF 5 Cites 0 Cited by

Patent Information

Application Number
CN202410523653.1
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Priority Date
2024-04-08
Filing Date
2024-04-28
Publication Date
2024-11-01
Estimated Expiration
2044-04-28

AI Technical Summary

Technical Problem

The treatment of osteoarthritis cartilage disease faces the problem of limited cell regeneration and renewal capabilities, and existing materials are difficult to effectively simulate the cellular environment and support cell growth.

Method used

Droplet microfluidic chip is used to mix hydrogel into gel phase and porous phase under 5~15°C. Droplets are formed by shearing, and porous phase is removed by ultraviolet light irradiation to form porous hydrocoagulation in a stable form. Glue microspheres, encapsulating cells to simulate the cellular environment.

Benefits of technology

The formed porous hydrogel microspheres are conducive to cell proliferation and stretching, suitable for the treatment of cartilage defects, providing an ideal carrier of biocompatibility and mechanical gradients.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118420932B_ABST
    Figure CN118420932B_ABST
Patent Text Reader

Abstract

A porous hydrogel microsphere and its preparation method and application belong to the field of biomaterial technology. The preparation method of porous hydrogel microspheres includes the following steps: using a droplet microfluidic chip to mix the hydrogel gelling phase and the pore-forming phase under the temperature condition of 5-15°C and form a first droplet through shearing; the hydrogel gelling phase contains methacrylated gelatin, polyethylene glycol diacrylate and a photoinitiator, and the pore-forming phase contains polyethylene oxide and gelatin; then the droplet flow formed by the first droplet is sheared by the oil phase to form a second droplet; the second droplet is solidified by ultraviolet light irradiation to form a hydrogel microsphere, and the pore-forming phase in the hydrogel microsphere is removed to obtain a porous hydrogel microsphere. It can form a stable morphology of GelMA hydrogel porous microspheres, and its porous structure is conducive to cell proliferation and extension.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present application relates to the technical field of biomaterials, and in particular to a porous hydrogel microsphere and a preparation method and application thereof. Background Art

[0002] Osteoarticular cartilage disease is a long-term chronic disease and one of the most common degenerative musculoskeletal diseases worldwide. Due to the lack of blood vessels, nerves, endogenous repair cells and growth factors in the degenerated or diseased joints, as well as a variety of different factors such as the depth, size, age and location of the defect, its self-regeneration and renewal ability is greatly limited. Therefore, the treatment of cartilage defects is a difficult problem.

[0003] As a high molecular cross-linked hydrophilic polymer network, GelMA hydrogel has high water content, high biocompatibility and extracellular matrix (ECM) simulation ability, and is an ideal candidate biomaterial. Porous hydrogel microspheres (HMPs) have a high surface to volume ratio, which can not only carry cells, but also better support cell extension, growth and cell interaction, accurately mimic ECM, and can manufacture multi-layer and multi-material hierarchical structures with ideal chemical, mechanical and biological gradients, thereby achieving regeneration of lesions, and are excellent materials for treating cartilage defects.

[0004] Based on this, the present application provides a porous hydrogel microsphere and a preparation method and application thereof. Summary of the invention

[0005] The present application provides a porous hydrogel microsphere and a preparation method and application thereof, which can form GelMA hydrogel porous microspheres with a stable morphology, and whose porous structure is conducive to cell proliferation and extension.

[0006] This application is implemented as follows:

[0007] In a first aspect, the present application provides a method for preparing porous hydrogel microspheres, comprising the following steps:

[0008] A droplet microfluidic chip is used to mix a hydrogel gelling phase and a pore-forming phase under a temperature condition of 5-15°C and form a first droplet through shearing; the hydrogel gelling phase contains methacrylated gelatin, polyethylene glycol diacrylate and a photoinitiator, and the pore-forming phase contains polyethylene oxide and gelatin;

[0009] The oil phase shears the droplet stream formed by the first droplet, thereby forming a second droplet;

[0010] The second liquid droplet is solidified by ultraviolet light irradiation to form a hydrogel microsphere, and the pore-forming phase in the hydrogel microsphere is removed to obtain a porous hydrogel microsphere.

[0011] In a possible embodiment, the concentration of the methacrylated gelatin in the hydrogel-forming phase is 0.05~0.15 g / mL, the volume concentration of polyethylene glycol diacrylate is 0.5~3%, and the concentration of the photoinitiator is 0.001~0.005 g / mL; optionally, the photoinitiator is phenyl (2,4,6-trimethylbenzoyl) lithium phosphate.

[0012] In a possible embodiment, the pore-forming phase contains polyethylene oxide and gelatin, the concentration of polyethylene oxide in the pore-forming phase is 0.01-0.016 g / mL, and the concentration of gelatin is 0.05-0.1 g / mL.

[0013] In one possible embodiment, the oil phase contains dimethicone and a surfactant.

[0014] In one possible embodiment, the surfactant includes cyclopentasiloxane and trimethylsiloxysilicate.

[0015] In one possible embodiment, the pore-forming phase is loaded with cells; optionally, the cells include bone marrow mesenchymal stem cells.

[0016] In a possible embodiment, the oil phase includes a hydrofluoroether and a nonionic fluorocarbon surfactant, and the volume of the nonionic fluorocarbon surfactant is 1-2% of the volume of the hydrofluoroether.

[0017] In a possible embodiment, the droplet microfluidic chip includes a first injection hole for introducing a hydrogel forming phase, a second injection hole for introducing a pore-forming phase, a third injection hole for introducing an oil phase, a first flow channel connected to the first injection hole, a second flow channel connected to the second injection hole, and a third flow channel connected to the third injection hole, the second flow channel is provided with a plurality of branch flow channels arranged at intervals, each branch flow channel is arranged perpendicular to the first flow channel to form a T-type shear, and the third flow channel is arranged crosswise with the first flow channel; optionally, the second injection hole is arranged in a right-angle trapezoid; optionally, the first injection hole, the second injection hole and the third injection hole are each provided with at least two rows of square holes.

[0018] In a second aspect, the present application provides a porous hydrogel microsphere, which is prepared by the preparation method of the porous hydrogel microsphere of the first aspect.

[0019] In a third aspect, the present application provides a use of the porous hydrogel microspheres according to the second aspect in the preparation of cartilage repair materials and osteogenic repair materials.

[0020] The embodiments of the present application have at least the following beneficial effects:

[0021] The method for preparing porous hydrogel microspheres in the embodiment of the present application is to mix the hydrogel gelling phase and the pore-forming phase under the temperature condition of 5-15°C and form the first droplet through shearing, wherein the temperature is controlled at 5-15°C so that the hydrogel gelling phase and the pore-forming phase are in a stably separated state. Although the two are mixed, they are not in a fused state. In the first droplet formed, the hydrogel gelling phase wraps the pore-forming phase, and then the oil phase shears the droplet flow formed by the first droplet, and the second droplet formed is the oil phase wrapping multiple first droplets, and finally the second droplet is solidified by ultraviolet light irradiation to form a hydrogel microsphere, and the pore-forming phase in the hydrogel microsphere is removed to form a porous hydrogel microsphere with a stable form.

[0022] It has been verified that the porous hydrogel microspheres of the embodiments of the present application have a porous structure that is conducive to cell proliferation and extension, and can be used to treat cartilage defects. BRIEF DESCRIPTION OF THE DRAWINGS

[0023] In order to more clearly illustrate the technical solutions of the embodiments of the present application, the drawings required for use in the embodiments will be briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present application and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without paying creative work.

[0024] Figure 1 This is a photo of the porous hydrogel microspheres in Example 1 of the present application under an optical microscope;

[0025] Figure 2 This is a photo of the porous hydrogel microspheres in Example 1 of the present application under a fluorescence microscope;

[0026] Figure 3 This is a cell staining diagram of the biocompatibility of the porous hydrogel microspheres of Example 1 of the present application;

[0027] Figure 4 This is a result diagram of the biocompatibility of the porous hydrogel microspheres of Example 1 of the present application;

[0028] Figure 5 This is a diagram showing the expansion and proliferation of bone marrow mesenchymal stem cells in the porous hydrogel microspheres of Example 1 after one day;

[0029] Figure 6 This is a diagram showing the expansion and proliferation of bone marrow mesenchymal stem cells in the porous hydrogel microspheres of Example 1 after 7 days;

[0030] Figure 7 The two-dimensional morphology of bone marrow mesenchymal stem cells in hydrogel;

[0031] Figure 8The three-dimensional morphology of bone marrow mesenchymal stem cells in hydrogel;

[0032] Fig. 9 Fluorescence microscopy images of the hydrogel gel-forming phase and the pore-forming phase after mixing and maintaining at temperatures of 5°C, 15°C and 25°C for 120 seconds;

[0033] Fig.10 The stratification diagram of the pore-forming phase without loaded cells in Example 1 at temperatures of 4° C., 8° C., 16° C., 24° C., and 37° C.;

[0034] Fig.11 A schematic diagram of a droplet microfluidic chip in a specific embodiment of the present application;

[0035] Fig.12 This is a picture of the cross arrangement of the first flow channel and the third flow channel of the droplet microfluidic chip in the specific implementation manner of the present application.

[0036] Icons: 11-first liquid injection hole; 12-second liquid injection hole; 13-third liquid injection hole; 14-first flow channel; 15-second flow channel; 151-branch flow channel; 16-third flow channel; 17-fourth flow channel; 18-fifth flow channel. DETAILED DESCRIPTION

[0037] The embodiments of the present application will be described in detail below in conjunction with the examples, but it will be appreciated by those skilled in the art that the following examples are only used to illustrate the present application and should not be considered as limiting the scope of the present application. In the examples, if specific conditions are not specified, they are carried out according to normal conditions or the conditions recommended by the manufacturer. If the manufacturer is not specified for the reagents or instruments used, they are all conventional products that can be purchased commercially.

[0038] The following is a detailed description of the porous hydrogel microspheres and their preparation methods and applications according to the embodiments of the present application:

[0039] In a first aspect, the present application provides a method for preparing porous hydrogel microspheres, comprising the following steps:

[0040] A droplet microfluidic chip is used to mix a hydrogel gelling phase and a pore-forming phase under a temperature condition of 5-15°C and form a first droplet through shearing; the hydrogel gelling phase contains methacrylated gelatin, polyethylene glycol diacrylate and a photoinitiator;

[0041] The oil phase shears the droplet stream formed by the first droplet, thereby forming a second droplet;

[0042] The second liquid droplet is solidified by ultraviolet light irradiation to form a hydrogel microsphere, and the pore-forming phase in the hydrogel microsphere is removed to obtain a porous hydrogel microsphere.

[0043] The preparation method of porous hydrogel microspheres of the embodiment of the present application, under the temperature condition of 5~15℃, the hydrogel gel phase and the pore phase are mixed and the first droplet is formed by shearing, wherein the temperature is controlled at 5~15℃ to make the hydrogel gel phase and the pore phase in a stable separation state, although the two are mixed, but not in a fusion state. The inventors of the present application found in the study that temperature has a very important influence on the stability of the two-phase emulsion containing both the hydrogel gel phase and the pore phase. When the temperature is too high, the pore phase of the small droplets distributed more evenly in the hydrogel gel phase will accelerate mutual diffusion and fusion to become large drops of PEO, which will cause the evenly distributed and interconnected pores to become a single large pore, which is not conducive to the formation of a porous structure with uniform size and stable structure. Optionally, the temperature is controlled to be any one of 5℃, 6℃, 7℃, 8℃, 9℃, 10℃, 11℃, 12℃, 13℃, 14℃ and 15℃ or any value between two of them.

[0044] Optionally, the temperature control adopts a cooling method, specifically, semiconductor cooling sheets can be used for cooling. It can be understood that in other embodiments, other cooling methods can also be used, such as water cooling, as long as the cooling effect can be achieved.

[0045] In the first droplet formed, the hydrogel gel phase wraps the pore-forming phase, and then the droplet flow formed by the first droplet is sheared by the oil phase. The second droplet formed is the oil phase wrapping multiple first droplets. Finally, the second droplet is solidified by ultraviolet light to form hydrogel microspheres. Only after the pore-forming phase in the hydrogel microspheres is removed can porous hydrogel microspheres with stable morphology be formed, and the clearer the pore structure.

[0046] The concentration of methacryloyl gelatin (GelMA) in the hydrogel phase is 0.05-0.15 g / mL, the content of polyethylene glycol diacrylate (PEGDA) is 0.5-3% by volume, the concentration of the photoinitiator is 0.001-0.005 g / mL, and the photoinitiator is phenyl (2,4,6-trimethylbenzoyl) lithium phosphate (LAP). Optionally, the concentration of methacrylated gelatin is any one of 0.05 g / mL, 0.08 g / mL, 0.10 g / mL, 0.12 g / mL and 0.15 g / mL, or a value between any two of them; the volume concentration of polyethylene glycol diacrylate is any one of 0.5%, 1.0%, 1.3%, 1.6%, 2.0%, 2.5% and 3%, or a value between any two of them; and the concentration of LAP is 0.001 g / mL, 0.003 g / mL or 0.005 g / mL.

[0047] The pore-forming phase contains polyoxyethylene (PEO for short) and gelatin, the concentration of polyoxyethylene in the pore-forming phase is 0.01-0.016 g / mL, and the concentration of gelatin is 0.05-0.1 g / mL. Optionally, the content of polyoxyethylene is any one of 0.01 g / mL, 0.012 g / mL, 10.014 g / mL or 0.016 g / mL, or a value between any two of them. The content of gelatin is any one of 0.05 g / mL, 0.07 g / mL, 0.08 g / mL and 0.1 g / mL, or a value between any two of them.

[0048] The oil phase contains dimethicone and a surfactant. In some embodiments, the surfactant includes cyclopentasiloxane and trimethylsiloxysilicate.

[0049] Further, in some embodiments, cells are loaded in the pore-forming phase; for example, the loaded cells include bone marrow mesenchymal stem cells. By loading cells in the pore-forming phase, the cells are embedded in the porous hydrogel microspheres, which is conducive to the simulation of the mechanical environment of the cartilage matrix and the growth and infiltration of cells. If the cells are loaded after the porous hydrogel microspheres are made and co-cultured with the cells, the cells are mostly attached to the surface of the microspheres and cannot grow well into the microspheres.

[0050] Exemplarily, the step of loading cells in the pore-forming phase comprises: digesting the cultured cells, centrifuging, removing the supernatant, and then adding the pore-forming phase (at 10 7 / mL concentration) and mix.

[0051] The second droplet is collected in a culture bottle (with culture medium) and irradiated under 15W ultraviolet light for about 15s, so that the second droplet solidifies to form hydrogel microspheres. Under ultraviolet light irradiation of this power, cell viability will not be greatly damaged; when the hydrogel microspheres enter the culture medium, a slight shake can make the pore-forming phase soluble in the culture medium, leaving the solidified cross-linked hydrogel and the cells adhered to its pore structure, and then placed in an incubator for culture, and the medium is changed the next day (the pore-forming phase and residual oil phase can be washed away when the medium is changed).

[0052] When cells are loaded in the pore-forming phase, the oil phase includes hydrofluoroether (model: HFE-7500) and non-ionic fluorocarbon surfactant. When cells are loaded in the pore-forming phase, it is difficult to demulsify and collect the microspheres by shearing dimethyl silicone oil to embed cells, while hydrofluoroether is volatile and has good biocompatibility. When embedding cells, the outlet of the microfluidic device can be directly connected to the culture medium to collect the microspheres, and then the hydrofluoroether is volatilized. Even if the hydrofluoroether is not completely volatilized, it can be removed when changing the cell medium.

[0053] It should be noted that the droplet microfluidic chip of the embodiment of the present application can achieve the above-mentioned function of forming the second droplet, and the specific structure is not limited. In some embodiments, the droplet microfluidic chip (refer to Fig.11 ) comprises a first injection hole 11 for introducing a hydrogel-forming phase, a second injection hole 12 for introducing a pore-forming phase, a third injection hole 13 for introducing an oil phase, a first flow channel 14 communicating with the first injection hole 11, a second flow channel 15 communicating with the second injection hole 12, and a third flow channel 16 communicating with the third injection hole 13, the second flow channel 15 is provided with a plurality of branch flow channels 151 arranged at intervals, each branch flow channel 151 is arranged perpendicularly to the first flow channel 14 to form a T-shaped shear, and the third flow channel 16 is arranged crosswise with the first flow channel 14 (refer to Fig.12 ).

[0054] The hydrogel-forming phase passes into the first flow channel 14 from the first injection hole 11, and the pore-forming phase passes into the second flow channel 15 from the second injection hole. The second flow channel 15 has a plurality of branch flow channels 151, and the branch flow channels 151 are arranged perpendicular to the first flow channel 14 to form a T-shaped shear, so that the size and spatial distribution of the pores formed are slightly more uniform.

[0055] Optionally, the second injection hole 12 is arranged in a right-angle trapezoidal shape, which is more conducive to fluid shearing.

[0056] Optionally, the first liquid injection hole 11, the second liquid injection hole 12 and the third liquid injection hole 13 are each provided with at least two rows of square holes, which can facilitate the discharge of bubbles, prevent larger impurities from entering, and make the liquid flow more stable.

[0057] Optionally, the droplet microfluidic chip is further provided with a fourth flow channel 17 and a fifth flow channel 18, the fourth flow channel 17 is connected to the outlet of the second droplet, the fifth flow channel 18 is connected to the fourth flow channel 17, the fifth flow channel 18 and the fourth flow channel 17 are both extended in an s-shape, and the bending length of the fifth flow channel 18 is longer than the bending length of the fourth flow channel 17, and the inner diameter is larger. The s-shaped extension of the fourth flow channel 17 can be beneficial to the mixing of the droplets (making the pore-forming phase evenly distributed) and the stable shape (spherical), and the fifth flow channel 18 is beneficial to slowing down the flow rate for easy observation under the microscope.

[0058] In a second aspect, the present application provides a porous hydrogel microsphere, which is prepared by the preparation method of the porous hydrogel microsphere of the first aspect.

[0059] It has been verified that the porous hydrogel microspheres of the embodiments of the present application have a porous structure that is conducive to cell proliferation and extension, and can be used to treat cartilage defects.

[0060] In a third aspect, the present application provides a use of the porous hydrogel microspheres according to the second aspect in the preparation of cartilage repair materials and osteogenic materials.

[0061] The porous hydrogel microspheres of the present application and their preparation method and application are further described in detail below in conjunction with the examples. Example

[0062] This embodiment provides a method for preparing porous hydrogel microspheres, which comprises the following steps:

[0063] (1) A droplet microfluidic chip is used to mix a hydrogel gelling phase and a pore-forming phase under a temperature condition of 5-15°C and form a first droplet through shearing; wherein the hydrogel gelling phase contains 0.1 g / mL methacrylated gelatin dissolved in PBS, 1% polyethylene glycol diacrylate, and 0.005 g / mL LAP photoinitiator, and the pore-forming phase contains 0.016 g / mL polyethylene oxide dissolved in PBS, 0.084 g / mL gelatin, and the pore-forming phase is loaded with cells, the specific ratio of which is 2×10 7 Bone marrow mesenchymal stem cells (BMSCs) at a concentration of 100 μg / mL.

[0064] (2) Shearing the droplet stream formed by the first droplet by the oil phase to form a second droplet; wherein the oil phase contains a hydrofluoroether and a non-ionic fluorocarbon surfactant, and the volume of the non-ionic fluorocarbon surfactant is 2% of the volume of the hydrofluoroether.

[0065] (3) Collect the second droplet in a culture bottle (with culture medium) and irradiate it under 15W ultraviolet light for about 15 seconds, so that the second droplet solidifies to form hydrogel microspheres. When the hydrogel microspheres enter the culture medium, they are slightly shaken to dissolve the pore-forming phase in the culture medium. The medium is changed the next day. When changing the medium, the pore-forming phase and residual oil phase can be washed away, thereby obtaining porous hydrogel microspheres. Example

[0066] This embodiment provides a method for preparing porous hydrogel microspheres. The preparation steps are different from those of embodiment 1, except that the temperature in step (1) of embodiment 2 is controlled at 15°C.

[0067] Comparative Example 1

[0068] This comparative example provides a method for preparing porous hydrogel microspheres. The preparation steps thereof are compared with those of Example 1, and the only difference is that in step (1) of Comparative Example 1, the temperature is controlled at 25°C.

[0069] Test Example 1

[0070] The porous hydrogel microspheres prepared in Example 1 were observed under an optical microscope and a fluorescence microscope, and the results were as follows: Figure 1 and Figure 2 shown.

[0071] like Figure 1 and Figure 2 As shown, the porous hydrogel microspheres prepared in Example 1 have both microscopic pores of chemical structure and macroscopic pores formed after the pore-forming phase is removed, presenting a spatial three-dimensional hierarchical pore structure in the microspheres.

[0072] Test Example 2

[0073] The porous hydrogel microspheres prepared in Example 1 were tested for biocompatibility, and the results are as follows: Figure 3 The specific experimental steps are as follows:

[0074] 1) Preparation of material extract

[0075] Preparation of material culture fluid extract: Prepare porous hydrogel microspheres aseptically, add culture fluid at a ratio of 0.1 g / mL, extract in a sealed glass container at 37°C for 24 hours, aspirate the supernatant and filter to obtain a 1 g / ml extract. During the experiment, dilute with cell culture medium to the required concentration.

[0076] 2) Cell preparation

[0077] The cultured fibroblasts were counted and the number of cells was 1×10 6 Calculate the required volume of cell suspension and resuspend the cells in culture medium.

[0078] 3) Add the extract

[0079] Add the resuspended cells to the diluted extracts of different concentrations, add 200uL to each well, add three rows of 96-well plates for each dilution, and add two rows of blank cells. Place the 96-well plates in a 37°C incubator for culture.

[0080] 4) Cell staining

[0081] Cell live and dead staining: Take cells cultured for 1, 4, and 7 days respectively, and stain them using Calcein-AM / PI cell double staining kit. The results are as follows Figure 3 and Figure 4 As shown, Figure 4 1%, 10% and 100% refer to the proportion of the extract. For example, 1% represents 1% extract and 99% culture medium.

[0082] from Figure 3 and Figure 4 It can be seen that the porous hydrogel microspheres of Example 1 have good biocompatibility.

[0083] Test Example 3

[0084] The porous hydrogel microspheres prepared in Example 1 were observed under a fluorescence microscope on the 1st and 7th days. The results were as follows: Figure 5 and Figure 6 shown.

[0085] The results showed that the cells expanded and proliferated well in the porous hydrogel microspheres of Example 1.

[0086] Test Example 4

[0087] The hydrogel gelling phase and the pore-forming phase were prepared. The hydrogel gelling phase contained 0.1 g / mL methacryloyl gelatin dissolved in PBS, 1% polyethylene glycol diacrylate, and 0.005 g / mL LAP photoinitiator. The pore-forming phase contained 0.016 g / mL polyethylene oxide dissolved in PBS, 0.084 g / mL gelatin, and the pore-forming phase was loaded with cells at a specific ratio of 2×10 7 Bone marrow mesenchymal stem cells (BMSCs) at a concentration of 100 μg / mL.

[0088] The hydrogel gelling phase and the pore-forming phase were mixed and blown for 8 seconds, then UV light was used for cross-linking for 15 seconds. After 7 days of culture, the cells were stained with phalloidin, and the extension and proliferation of bone marrow mesenchymal stem cells were observed using a confocal microscope. The results are shown in Figure 2. Figure 7 and Figure 8 shown.

[0089] The results showed that the cells expanded and proliferated well in the hydrogel of Example 1.

[0090] Test Example 5

[0091] The hydrogel gel phase and the pore-forming phase of Example 1 were first dripped with 2 μL of the hydrogel gel phase, and then 1 μL of the pore-forming phase was dripped into the hydrogel gel phase. During the dripping process, the temperature of each group was controlled at 5°C, 15°C and 25°C respectively, and the treatment was carried out for 120s, and then observed under a fluorescence microscope. The results are as follows: Fig. 9 As shown in the figure, the green fluorescence is the hydrogel-forming phase, and the red fluorescence is the pore-forming phase.

[0092] from Fig. 9 It can be seen from the results that when the temperature is 25°C, the hydrogel gel phase and the pore-forming phase are partially fused, while when the temperature is 5°C and 15°C, the hydrogel gel phase and the pore-forming phase are stably separated. This indicates that in the embodiment of the present application, controlling the temperature at 5°C or 15°C in step (1) is conducive to obtaining porous hydrogel microspheres with stable morphology.

[0093] Test Example 6

[0094] The pore-forming phase without cell loading in Example 1 was treated at 4°C, 8°C, 16°C, 24°C and 37°C, respectively, and the time for the pore-forming phase to separate was recorded. The results are shown in FIG. Fig.12 As shown. Fig.10It can be seen that the lower the temperature, the longer it takes for the pore-forming phase to be stratified, and the higher the temperature, the shorter the time it takes for the pore-forming phase to be stratified. This shows that the embodiment of the present application adopts controlling the temperature at 5°C and 15°C, which is conducive to keeping the pore-forming phase in a mixed state.

[0095] The above are only specific embodiments of the present application and are not intended to limit the present application. For those skilled in the art, the present application may have various modifications and variations. Any modification, equivalent replacement, improvement, etc. made within the spirit and principle of the present application shall be included in the protection scope of the present application.

Claims

1. A method for preparing porous hydrogel microspheres, characterized in that: The following steps are involved: A droplet microfluidic chip is used to mix a hydrogel gelling phase and a pore-forming phase under a temperature condition of 5-15°C and form a first droplet through shearing; the hydrogel gelling phase contains methacryloyl gelatin, polyethylene glycol diacrylate and a photoinitiator; the concentration of the methacryloyl gelatin in the hydrogel gelling phase is 0.05-0.15 g / mL, the volume concentration of the polyethylene glycol diacrylate is 0.5-3%, and the concentration of the photoinitiator is 0.001-0.005 g / mL; the pore-forming phase contains polyethylene oxide and gelatin, the concentration of the polyethylene oxide in the pore-forming phase is 0.01-0.016 g / mL, and the concentration of the gelatin is 0.05-0.1 g / mL; Shearing the droplet stream formed by the first droplet by the oil phase, thereby forming a second droplet; The second liquid droplets are solidified to form hydrogel microspheres by ultraviolet light irradiation, and the pore-forming phase in the hydrogel microspheres is removed to obtain porous hydrogel microspheres; The droplet microfluidic chip includes a first injection hole for introducing the hydrogel forming phase, a second injection hole for introducing the pore-forming phase, a third injection hole for introducing the oil phase, a first flow channel connected to the first injection hole, a second flow channel connected to the second injection hole, and a third flow channel connected to the third injection hole, the second flow channel is provided with a plurality of branch flow channels arranged at intervals, each of the branch flow channels is arranged perpendicular to the first flow channel to form a T-shaped shear, and the third flow channel is arranged crosswise with the first flow channel.

2. The method for preparing porous hydrogel microspheres according to claim 1, characterized in that: The photoinitiator is phenyl (2, 4, 6-trimethylbenzoyl) lithium phosphate.

3. The method for preparing porous hydrogel microspheres according to claim 1 or 2, characterized in that: The oil phase contains dimethyl silicone oil and a surfactant.

4. The method for preparing porous hydrogel microspheres according to claim 3, characterized in that: The surfactants include cyclopentasiloxane and trimethylsiloxysilicate.

5. The method for preparing porous hydrogel microspheres according to claim 1 or 2, characterized in that: The pore-forming phase is loaded with cells.

6. The method for preparing porous hydrogel microspheres according to claim 5, characterized in that: The cells include bone marrow mesenchymal stem cells, fibroblasts, and adipose mesenchymal stem cells.

7. The method for preparing porous hydrogel microspheres according to claim 6, characterized in that: The oil phase comprises hydrofluoroether and a nonionic fluorocarbon surfactant, and the volume of the nonionic fluorocarbon surfactant is 1-2% of the volume of the hydrofluoroether. 8 . The method for preparing porous hydrogel microspheres according to claim 1 , wherein the first injection hole, the second injection hole and the third injection hole are each provided with at least two rows of square holes. 9 . The method for preparing porous hydrogel microspheres according to claim 1 , wherein the second injection hole is arranged in a right-angle trapezoidal shape.

10. A porous hydrogel microsphere, prepared by the method for preparing the porous hydrogel microsphere according to any one of claims 1 to 9.

11. Use of the porous hydrogel microspheres according to claim 10 in preparing cartilage repair materials and osteogenic repair materials.

Citation Information

Patent Citations

  • Preparation method of hydrogel porous microspheres and porous scaffold material

    CN109880151A

  • Method for preparing injectable porous hydrogel microspheres by microfluidic ice crystal method and application of injectable porous hydrogel microspheres

    CN112409553A

  • Porous hydrogel microsphere and preparation method thereof

    CN113801367A

  • Multi-level porous injectable hydrogel as well as preparation and application thereof

    CN117138111A

  • Gel microsphere-based 3D printing bio-ink and application thereof

    WO2022237002A1